business
Indian billionaires buy foreign companies as growth slows at home
Key takeaways
- It marked the biggest overseas acquisition by an Indian company in nearly two decades and followed a string of high-profile international deals by Indian firms in recent months.
- Data from consultancy Grant Thornton shows that 162 Indian companies spent more than $18bn on outbound acquisitions in 2025 - a 34% increase from the previous year.
- "We could cross $15bn in deal value in just the first half of this year," Sumeet Abrol, partner and national leader at Grant Thornton, told the BBC.
Nikhil Inamdar Mumbai Bloomberg via Getty Images India's Sun Pharmaceuticals paid $11.75bn to buy New York-listed Organon & Co In late April, India's Sun Pharmaceuticals agreed to pay $11.75bn (£8.59bn) to acquire New York-listed women's health and biosimilars firm Organon & Co.
It marked the biggest overseas acquisition by an Indian company in nearly two decades and followed a string of high-profile international deals by Indian firms in recent months.
These include Tata Motors' $4.4bn acquisition of Turin-based vehicle maker Iveco, IT company Coforge's $2.35bn purchase of Silicon Valley-based AI firm Encora and the Bajaj Group buying a 23% stake in global insurance giant Allianz SE earlier in 2025.
Article preview — originally published by BBC Business. Full story at the source.
Read full story on BBC Business →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from BBC Business alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop